Basics Evofem Biosciences, Inc. Evofem Biosciences Inc provides woman-controlled protection from sexually transmitted infections. It addresses women's unmet medical needs through the discovery, development and commercialization of healthcare products. IPO Date: November 20, 2014 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.97% Avg Daily Range (30 D): $0.00 | 0.00% Avg Daily Range (90 D): $0.00 | 0.00% Institutional Daily Volume Avg Daily Volume: 2.8M Avg Daily Volume (30 D): .25M Avg Daily Volume (90 D): .47M Trade Size Avg Trade Size (Sh.): 678 Avg Trade Size (Sh.) (30 D): 9,845 Avg Trade Size (Sh.) (90 D): 15,185 Institutional Trades Total Inst.Trades: 68 Avg Inst. Trade: $2.21M Avg Inst. Trade (30 D): $.5M Avg Inst. Trade (90 D): $.74M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.6M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 1.01K         News Apr 14, 2025 @ 12:41 PM Evofem Biosciences to Present at Emerging Growth C... Source: Prnewswire Mar 26, 2025 @ 12:47 PM Evofem Expects Significant Reduction in PHEXXI Man... Source: Prnewswire Feb 13, 2025 @ 2:16 PM Evofem Strengthens SOLOSEC Intellectual Property w... Source: Prnewswire Aug 11, 2022 @ 9:28 AM Why Invitae Climbed Around 279%; Here Are 98 Bigge... Source: Lisa Levin Aug 10, 2022 @ 7:52 AM Why Avalo Therapeutics Surged 32%; Here Are 111 Bi... Source: Lisa Levin Financials   TTM Q2 2022 Q1 2022 Basic EPS $.31 $-4.57 $-2.88 Diluted EPS $.31 $-4.57 $-2.88 Revenue $ .18M $ 6.03M $ 4.25M Gross Profit $ -.2M $ 4.75M $ 3.19M Net Income / Loss $ -8.34M $ -125.98M $ -31.89M Operating Income / Loss $ -12.05M $ -24.42M $ -28.93M Cost of Revenue $ .38M $ 1.29M $ 1.07M Net Cash Flow $ -5.07M $ 14.53M $ -5.86M PE Ratio 0.03     Splits May 18, 2023:   1:125 May 06, 2022:   1:15 Jan 18, 2018:   1:6